Gallman Cari
SEC CIK 1995058 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMY | Bristol Myers Squibb | EVP, GC | 14.2K | — | — | 19 | 2024-03-10 | 2026-08-01 |
Most active insiders at BMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elkins David V | EVP, CFO | — | $1.85M |
| 2 | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| 3 | Holzer Phil M | SVP, Ctrl | — | $33.8K |
| 4 | Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| 5 | Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| 6 | Poole Ahn Amanda | EVP, CHRO | — | — |
| 7 | Gallman Cari | EVP, GC | — | — |
| 8 | Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| 9 | Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| 10 | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-04 16:07 | 2026-08-01 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | M - OptEx | $0.00 | +1,061 | 14.2K | +8% | $0 |
| D | 2026-08-04 16:07 | 2026-08-01 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | F - Tax | $65.31 | -543 | 13.6K | -4% | -$35.5K |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | F - Tax | $60.13 | -2,165 | 11.8K | -15% | -$130.2K |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | M - OptEx | $0.00 | +6,980 | 17.0K | +69% | $0 |
| DM | 2026-03-12 | 2026-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | J - Other | $0.00 | -2,750 | 12.2K | -18% | $0 |
| D | 2025-10-06 | 2025-10-02 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | M - OptEx | $0.00 | +4,558 | 13.4K | +52% | $0 |
| D | 2025-10-06 | 2025-10-02 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | F - Tax | $45.73 | -2,332 | 11.1K | -17% | -$106.6K |
| D | 2025-08-05 | 2025-08-01 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | F - Tax | $44.23 | -543 | 8,840 | -6% | -$24.0K |
| D | 2025-08-05 | 2025-08-01 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, GC | M - OptEx | $0.00 | +1,061 | 9,383 | +13% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +7,588 | 11.6K | +188% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | J - Other | $0.00 | -2,345 | 9,612 | -20% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | F - Tax | $63.11 | -1,940 | 5,705 | -25% | -$122.4K |
| D | 2024-10-03 | 2024-10-02 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +4,558 | 6,667 | +216% | $0 |
| D | 2024-10-03 | 2024-10-02 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | F - Tax | $53.76 | -1,648 | 5,019 | -25% | -$88.6K |
| D | 2024-08-05 | 2024-08-01 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +1,061 | 2,493 | +74% | $0 |
| D | 2024-08-05 | 2024-08-01 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | F - Tax | $48.17 | -384 | 2,109 | -15% | -$18.5K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +2,761 | 2,655 | New | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | J - Other | $0.00 | -839 | 666 | -56% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Gallman Cari | EVP, Corp. Affairs | F - Tax | $53.79 | -696 | 561 | -55% | -$37.4K |
Purchase Sale Sale after option exercise All abbreviations